Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Mesalamine Treatment Report
What is Mesalamine?

Mesalamine, a derivative of 5-aminosalicylic acid, is an anti-inflammatory agent. Orally it is used to treat and maintain remission of mild to moderate ulcerative colitis. Rectal administration is used to treat active mild-to-moderate distal ulcerative colitis, proctosigmoiditis, or proctitis.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell 		# of patients evaluated by
Ulcerative colitis 2 0

See all 2 patients currently taking Mesalamine

Mouse over the table for more information

Dosages

  2.4 g daily 2400 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Duration See details about how long patients take this treatment ▼

Currently Taking Mesalamine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 20, 2010.